BiVictriX Therapeutics PLC BVX:London Stock Exchange

RT Quote | Exchange | GBp
Last | 09/29/22 BST
21.50UNCH (UNCH)
52 week range
13.60 - 35.00
Loading...
  • Open21.50
  • Day High0.00
  • Day Low0.00
  • Prev Close21.50
  • 52 Week High35.00
  • 52 Week High Date01/18/22
  • 52 Week Low13.60
  • 52 Week Low Date08/31/22

Key Stats

  • Market Cap16.35M
  • Shares Out66.12M
  • 10 Day Average Volume123,300.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-27.12

KEY STATS

  • Open21.50
  • Day High0.00
  • Day Low0.00
  • Prev Close21.50
  • 52 Week High35.00
  • 52 Week High Date01/18/22
  • 52 Week Low13.60
  • 52 Week Low Date08/31/22
  • Market Cap16.35M
  • Shares Out66.12M
  • 10 Day Average Volume123,300.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-27.12

RATIOS/PROFITABILITY

  • EPS (TTM)-5.48
  • P/E (TTM)-3.92
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BiVictriX Therapeutics PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BiVictriX Therapeutics plc is a United Kingdom-based drug discovery and development company focused on developing cancer therapeutics. The Company is building a novel pipeline of therapeutics that have cancer selectivity by reducing harmful side-effects. The Company has developed Bi-Cygni therapeutics, which are uniquely selective for cancer types, to enable higher dosing and more aggressive cancer eradication without causing harmful side effects. Bi-Cygni therapeutics are...
Address
Bio Hub, Alderley Park
Alderley Edge
SK10 4TG
United Kingdom